Piper Sandler Reiterates Overweight on OrthoPediatrics, Raises Price Target to $30

Benzinga · 2d ago
Piper Sandler analyst Matt O'Brien reiterates OrthoPediatrics (NASDAQ:KIDS) with a Overweight and raises the price target from $25 to $30.